英科医疗: 关于2025年限制性股票激励计划首次授予部分登记完成调整英科转债转股价格的公告

Group 1 - The company announced an adjustment to the conversion price of its convertible bonds, changing from RMB 3.26 per share to RMB 3.42 per share, effective from July 22, 2025 [1][4] - The adjustment is a result of the completion of the registration for the first grant of restricted stock under the 2025 incentive plan, which involves 12.8021 million shares, accounting for approximately 1.9946% of the total share capital before the registration [2][3] - Following the registration, the total share capital of the company will increase from 641,832,807 shares to 654,634,907 shares [3] Group 2 - The adjustment of the conversion price is in accordance with the regulations outlined in the company's prospectus and relevant guidelines from the China Securities Regulatory Commission [4] - The calculation for the new conversion price considers the previous conversion price, the price of newly issued shares, and the percentage increase in share capital due to the restricted stock grant [4]